Balyasny Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,800
Closed -$340K – 3494
2026
Q1
$340K Sell
1,800
-6,600
-79% -$1.39M ﹤0.01% 2515
2025
Q4
$1.67M Buy
8,400
+7,200
+600% +$1.46M ﹤0.01% 1957
2025
Q3
$244K Buy
+1,200
New +$213K ﹤0.01% 2656
2020
Q2
– Sell
-200,000
Closed -$2.88M – 1480
2020
Q1
$2.88M Buy
+200,000
New +$5.74M 0.03% 526
2014
Q3
– Sell
-200,000
Closed -$9.39M – 855
2014
Q2
$9.39M Buy
+200,000
New +$9.04M 0.11% 245

Other funds holding THC

Balyasny Asset Management's THC Position: Q2 2026 in Review

Balyasny Asset Management increased its Tenet Healthcare (THC) stake by 55% in Q2 2026, buying an estimated $118K and bringing the position to 1,807 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

Balyasny Asset Management first reported a position in THC in Q2 2013 and has held it in 39 quarters since. The position peaked at $70.3M in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Balyasny Asset Management held 1,807 shares of Tenet Healthcare worth $338K as of Q2 2026.
  • Balyasny Asset Management bought 644 Tenet Healthcare shares in Q2 2026, an estimated $118K.
  • Tenet Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2673 holding.
  • Balyasny Asset Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Balyasny Asset Management's Tenet Healthcare position peaked at $70.3M in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.